Insights on Health Care
1352 total results. Page 4 of 55.
Health care enforcement targeting diagnostic and laboratory services accelerated in 2025 and shows no signs of slowing down in 2026.
Welcome to the April 2026 issue of “As the (Customs and Trade) World Turns,” our monthly newsletter where we compile essential updates from the customs and trade world over the past month. We bring you the most recent and significant insights in an accessible format, concluding with our main takeaways — aka “And the Fox Says…” — on what you need to know.
In a recent ruling out of the District of Minnesota, a federal magistrate judge directed UnitedHealthcare (UHC) to turn over an expansive set of documents in the class action Estate of Lokken v. UnitedHealth Group, Inc., alleging that the health insurer used an artificial intelligence (AI) algorithm to improperly withhold post-acute care coverage from Medicare Advantage enrollees.
Pat Naples was featured on a recent proposal from the US Treasury Department that would share monetary penalties with healthcare whistleblowers.
While Section 232 tariffs have so far been largely a metals-and-autos story, pharma has now officially joined the narrative.
ArentFox Schiff’s Pat Naples discusses with Medical Economics the US Centers for Medicare & Medicaid Services’ (CMS) expanded anti‑fraud enforcement and its impact on health care providers.
Michelle J. Shapiro to speak at Executive Women in Bio (EWIB) virtual program – Implementing Lessons Learned From Enforcement Developments to Improve Corporate Compliance.
Forget science fiction — the race to wire computers directly into the human brain is well underway, and it is moving fast.
On March 9, a federal court in Connecticut issued a decision in Abira Medical Laboratories LLC v. Aetna Inc. et al. that underscores the continuing importance of clear and comprehensive assignment-of-benefits language in payer disputes.
ArentFox Schiff, in collaboration with Consilio, will host the 2026 Chicago Pharma Forum on May 6, 2026, bringing together pharmaceutical industry leaders and in‑house counsel in the Chicago area for a full day of discussion and networking.
Health Care Industry Group Co-Leader Annie Chang Lee will kick off the California Ambulatory Surgery Association’s (CASA) Administrator Mastery Series as the inaugural speaker on March 25, 2026.
Health Care Industry Co-Leader Nadia Patel was quoted on Johnson & Johnson’s Janssen Products LP unit’s appeal to the Third Circuit Court of Appeals to overturn the 2025 jury $1.6 billion verdict — the largest False Claims Act (FCA) judgment in history.
As we continue to move through 2026, the life sciences landscape is shaped by a convergence of regulatory, enforcement, and market access developments that demand heightened attention from industry stakeholders.
Join attorneys Linda Jackson, Douglas Grimm, Jeff Weston, and Pat Naples as they address recent developments affecting the use of noncompete agreements in the health care industry.
The rapidly expanding consumer biomarker testing market — a major pillar of the longevity ecosystem — has produced its first major lawsuit between competitors.
The US Food and Drug Administration (FDA) issued a final rule on March 5 that will change National Drug Codes (NDCs) from several different 10‑digit formats to one standard 12‑digit format.
ArentFox Schiff’s recently launched Longevity & Healthspan Industry Group and Group Leader Gayland O. Hethcoat II were featured by Longevity.Technology in an article about how the emergence of longevity-focused legal counsel is a maturity marker for the field.